Kesar Vaccine Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 47.18%
- Profit Growth 1755.93%
- Ebitda 5052.28%
- Net Worth 5.58%
- Total Assets 7.82%
About Kesar Vaccine Distributors
Kesar Vaccine Distributors Private Limited (KVDPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2012 and has a history of 12 years and ten months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Arjun Keshri, Amar Keshri, and Mona Keshri serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U15209BR2012PTC018382
- Company No.
018382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Kesar Vaccine Distributors?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Keshri  | Director | 27-Mar-2012 | Current |
| Amar Keshri | Director | 27-Mar-2012 | Current |
| Mona Keshri | Director | 27-Mar-2012 | Current |
Financial Performance of Kesar Vaccine Distributors.
Kesar Vaccine Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.18% increase. The company also saw a substantial improvement in profitability, with a 1755.93% increase in profit. The company's net worth moved up by a moderate rise of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kesar Vaccine Distributors?
In 2023, Kesar Vaccine Distributors had a promoter holding of 33.33% and a public holding of 66.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kalsham Food Overseas Private LimitedAmar Keshri and Mona Keshri are mutual person
- Connectlife Pharma Private Limited
Amar Keshri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kesar Vaccine Distributors?
Unlock and access historical data on people associated with Kesar Vaccine Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kesar Vaccine Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesar Vaccine Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
